0      0


EU24CEMAR1/SES113 - Maximizing Gene Therapy Doses for Patients


‐ Mar 13, 2024 2:30pm

Gene therapies hold tremendous potential, yet manual operations, product loss, and high costs impede patient access to vital treatments. The fill/finish processes are pivotal in optimizing drug product availability. Precision is paramount in formulating, filling, and packaging the therapies to preserve their efficacy and integrity. CBM addresses these challenges by leveraging advanced technologies like the adaptable Optima FillCell. This flexible and modular system streamlines operations, reducing reliance on manual labor and mitigating the risk of errors and contamination. Real-time monitoring and data analysis provide crucial insights, empowering manufacturers to optimize production parameters and minimize wastage, ultimately increasing the number of viable drug vials. By enhancing efficiency and maximizing overall yield, CBM contributes to expanding patient access to transformative gene therapies.